Pharmacotherapy rounds are designed for pharmacy residents and fellows, residency and fellowship preceptors, faculty, and practicing pharmacists. Activities are offered free of charge to all participants.
Pharmacotherapy Rounds at the University of Maryland School of Pharmacy are held in room N211, unless otherwise noted.
Also available is a printer-friendly 2021-2022 PT Rounds Schedule, including topic and application deadlines.
Wednesday, February 2, 12:30-1:30 p.m.
Keeping an Eye on STIs: Updates to the CDC’s Treatment Guidelines for Sexually Transmitted Infections - Ryan Nguyen, PharmD
Updates to the use of dexmedetomidine for sedation in critically ill patients - Sara Hall, PharmD
Wednesday, February 9, 12:30-1:30 p.m.
Bad Blood: DOACs vs. Warfarin - Ibtihal Makki, PharmD
Wednesday, February 16, 12:30-1:30 p.m.
AFFIRMing the Benefits of IV Iron in Heart Failure - Christian Macaspac, PharmD
SGLT2 inhibitors for Diabetes, Heart Failure, now Hypertension? - Cynthia Mock, PharmD
Wednesday, February 23, 12:30-1:30 p.m.
Hot off the agar plate! - The role of imipenem-cilastatin-relebactam for multi-drug resistant (MDR) pathogens in the inpatient setting - Asma Ul Husna, PharmD
DOACs are Weighing In: To load or Not to Load - Nuances of Prescribing in Obesity - Brittany Olbert, PharmD
Wednesday, March 2, 12:30-1:30 p.m.
Hitting the Target; Post-Cardiac Arrest Care - Daniel Cericola, PharmD
Wednesday, March 9, 12:30-1:30 p.m.
Optimizing Vancomycin Monitoring in Pediatrics: AUC vs Trough Monitoring - Nadia Adjin-Tettey, PharmD
The Weight is Over! Pharmacotherapy of Weight Loss Medications - Sharon Vadapalli, PharmD
Wednesday, March 16, 12:30-1:30 p.m.
JAK is back: revisiting Janus Kinase inhibitor indications and their recent cardiovascular safety concerns - Chaya Lachman, PharmD
Paralytics Paradigm: Continuous vs. Intermittent - Jahnavi Patel, PharmD
Wednesday, March 30, 12:30-1:00 p.m.
MRSA Nares and Indications for Use: Is the Answer to Antibiotic De-escalation Under the Tip of Our Noses? - Victoria Fusco, PharmD
Wednesday, April 6, 12:30-1:30 p.m.
Direct Oral Anticoagulant Use in Patients with Metastases - Pari Majethia, PharmD
Wednesday, April 13, 12:30-1:30 p.m.
Will You (B)MI DOAC?: VTE Management with DOACs in Obesity - Clynton Musngi, PharmD
Cefiderocol: The Trojan Horse Antibiotic and Its Entrance into the Treatment of Drug-Resistant Pathogens - Lilly Lin, PharmD
Wednesday, May 4, 12:30-1:30 p.m.
Prevention in an Injection: Cabotegravir for PrEP - Paige Gilk, PharmD
Wednesday, May 11, 12:30-1:30 p.m.
VICTORY for vericiguat... or not? An Evaluation of Vericiguat in Heart Failure - Renee Mott, PharmD
What’s the DIFFerence? The 2021 IDSA/SHEA Clostridioides difficile Treatment Guideline Updates - Sara Foreman, PharmD
|The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity meets the ACPE criteria for one contact hour (0.1 CEU) of continuing education credit. Statements of credit will be posted to CPE Monitor within 60 days of the activity date for participants who successfully complete the activity. Successful completion of this activity requires your signature on the sign-in sheet (or if participating virtually, your name and email address entered into the Blackboard Collaborative chat), the completion of an online activity evaluation form, and participation in the entire activity. The online activity evaluation must be completed within three days following the conclusion of the activity. This activity is fully provided by the University of Maryland School of Pharmacy.|
|The Johns Hopkins Hospital Department of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|